These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 27537990)

  • 1. Effect of Psoriatic Arthritis on Treatment Response in Patients With Moderate to Severe Psoriasis.
    Greb JE; Garber C; Gottlieb AB
    J Drugs Dermatol; 2016 Aug; 15(8):917-22. PubMed ID: 27537990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment use and satisfaction among patients with psoriasis and psoriatic arthritis: results from the NORdic PAtient survey of Psoriasis and Psoriatic arthritis (NORPAPP).
    Tveit KS; Duvetorp A; Østergaard M; Skov L; Danielsen K; Iversen L; Seifert O
    J Eur Acad Dermatol Venereol; 2019 Feb; 33(2):340-354. PubMed ID: 30242921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologic and Conventional Systemic Therapies Show Similar Safety and Efficacy in Elderly and Adult Patients With Moderate to Severe Psoriasis.
    Garber C; Plotnikova N; Au SC; Sorensen EP; Gottlieb A
    J Drugs Dermatol; 2015 Aug; 14(8):846-52. PubMed ID: 26267729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psoriatic arthritis treatment regimens, therapy duration and reasons for cessation in the biologics era: a multi-centre Australian study.
    Tymms K; Kelly A; Bird P; Griffiths H; de Jager J; Littlejohn G; Louw S; Roberts L; Youssef P; Zochling J; Nichols D
    Int J Rheum Dis; 2018 Feb; 21(2):510-516. PubMed ID: 28730757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment patterns and health care costs for patients with psoriatic arthritis on biologic therapy: a retrospective cohort study.
    Zhu B; Edson-Heredia E; Gatz JL; Guo J; Shuler CL
    Clin Ther; 2013 Sep; 35(9):1376-85. PubMed ID: 23954091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. US Perspectives in the Management of Psoriasis and Psoriatic Arthritis: Patient and Physician Results from the Population-Based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) Survey.
    Lebwohl MG; Kavanaugh A; Armstrong AW; Van Voorhees AS
    Am J Clin Dermatol; 2016 Feb; 17(1):87-97. PubMed ID: 26718712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physician perspectives in the management of psoriasis and psoriatic arthritis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis survey.
    van de Kerkhof PC; Reich K; Kavanaugh A; Bachelez H; Barker J; Girolomoni G; Langley RG; Paul CF; Puig L; Lebwohl MG
    J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):2002-10. PubMed ID: 25885420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of psoriatic arthritis on the efficacy of adalimumab and on the treatment response of other markers of psoriasis burden: subanalysis of the BELIEVE study.
    Paul C; van de Kerkhof P; Puig L; Unnebrink K; Goldblum O; Thaçi D
    Eur J Dermatol; 2012; 22(6):762-9. PubMed ID: 23178916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and clinical features of psoriatic arthritis in psoriasis patients in Spain. Limitations of PASE as a screening tool.
    López Estebaránz JL; Zarco-Montejo P; Samaniego ML; García-Calvo C;
    Eur J Dermatol; 2015; 25(1):57-63. PubMed ID: 25333645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Tofacitinib for the Treatment of Moderate-to-Severe Chronic Plaque Psoriasis in Patient Subgroups from Two Randomised Phase 3 Trials.
    Menter MA; Papp KA; Cather J; Leonardi C; Pariser DM; Krueger JG; Wohlrab J; Amaya-Guerra M; Kaszuba A; Nadashkevich O; Tsai TF; Gupta P; Tan H; Valdez H; Mallbris L; Tatulych S
    J Drugs Dermatol; 2016 May; 15(5):568-80. PubMed ID: 27168266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early treatment of psoriatic arthritis is associated with improved patient-reported outcomes: findings from the etanercept PRESTA trial.
    Kirkham B; de Vlam K; Li W; Boggs R; Mallbris L; Nab HW; Tarallo M
    Clin Exp Rheumatol; 2015; 33(1):11-9. PubMed ID: 25535650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics.
    Papoutsaki M; Chimenti MS; Costanzo A; Talamonti M; Zangrilli A; Giunta A; Bianchi L; Chimenti S
    J Am Acad Dermatol; 2007 Aug; 57(2):269-75. PubMed ID: 17574299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are biologics combined with methotrexate better than biologics monotherapy in psoriasis and psoriatic arthritis: A meta-analysis of randomized controlled trials.
    Xie Y; Liu Y; Liu Y
    Dermatol Ther; 2021 May; 34(3):e14926. PubMed ID: 33655646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of brodalumab in subpopulations of patients with difficult-to-treat moderate-to-severe plaque psoriasis.
    Papp K; Menter A; Strober B; Kricorian G; Thompson EH; Milmont CE; Nirula A; Klekotka P
    J Am Acad Dermatol; 2015 Mar; 72(3):436-439.e1. PubMed ID: 25553889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burden and Disease Characteristics of Patients with Psoriatic Arthritis: A Population-based Cross-sectional Study.
    Tekin HG; Wu JJ; Burge R; Birt J; Egeberg A
    J Rheumatol; 2019 Jul; 46(7):716-720. PubMed ID: 30824662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous versus intermittent therapy for moderate-to-severe psoriasis.
    Ramirez-Fort MK; Levin AA; Au SC; Gottlieb AB
    Clin Exp Rheumatol; 2013; 31(4 Suppl 78):S63-70. PubMed ID: 24129141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limited association between scalp psoriasis and psoriatic arthritis severity and treatment response.
    de Vlam K; Mallbris L; Szumski A; Jones H
    Clin Exp Rheumatol; 2017; 35(1):141-144. PubMed ID: 27606545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rates of Cardiovascular Disease and Major Adverse Cardiovascular Events in Patients With Psoriatic Arthritis Compared to Patients Without Psoriatic Arthritis.
    Li L; Hagberg KW; Peng M; Shah K; Paris M; Jick S
    J Clin Rheumatol; 2015 Dec; 21(8):405-10. PubMed ID: 26406567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaco-utilization of biologic drugs in patients affected by psoriasis, psoriatic arthritis and ankylosing spondylitis in an Italian real-world setting.
    Zagni E; Colombo D; Fiocchi M; Perrone V; Sangiorgi D; Andretta M; De Sarro G; Nava E; Degli Esposti L
    Expert Rev Pharmacoecon Outcomes Res; 2020 Oct; 20(5):491-497. PubMed ID: 32701033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tailored treatment options for patients with psoriatic arthritis and psoriasis: review of established and new biologic and small molecule therapies.
    Elyoussfi S; Thomas BJ; Ciurtin C
    Rheumatol Int; 2016 May; 36(5):603-12. PubMed ID: 26892034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.